![Adam Hargreaves](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 1 M $ al 30/06/2026
Adam Hargreaves is the founder of Pathcelerate Ltd. Dr. Hargreaves is the Independent Non-Executive Chairman at Aptamer Group Plc since 2024.
Dr. Hargreaves was President at the British Society of Toxicologic Pathology.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
APTAMER GROUP PLC 5,08 % | 25/03/2026 | 175.379.305 ( 5,08 % ) | 1 M $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| APTAMER GROUP PLC | Presidente | 14/08/2024 |
| Empresas | Cargo | Fin |
|---|---|---|
Pathcelerate Ltd. | Fundador | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
| Empresas privadas | 2 |
|---|---|
Aptamer Group Plc
 Aptamer Group Plc BiotechnologyHealth Technology Engages in research and development of biotechnology products | Health Technology |
Pathcelerate Ltd. |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
